The FDA typically follows the recommendations of its advisory panels but is not required to do so. If cleared for use, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

Thinking about what to do with Eli Lilly shares? You’re certainly not alone. The stock has been climbing the leaderboard for ...

Eli Lilly and Company (NYSE:LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

Elevated brain amyloid is a potential early sign of Alzheimer's disease, even in people who are cognitively normal. "This ...

Julianne Moore had an important message for people watching the World Series this week, and I was one of them. Maybe you saw it, too?

The EU medicines regulator on Friday rejected Eli Lilly's (LLY.N), opens new tab Alzheimer's drug, saying the treatment's ability to slow cognitive decline was not large enough to outweigh the risk of ...

Fresh off launching a national ad campaign to promote its Alzheimer’s treatment Kisunla, Eli Lilly is unveiling another effort focused on brain health — with some celebrity support. In 2015, Julianne ...

Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...